Table 3 Associations between recurrence and clinicopathologic parameters

WMDA (n = 152)

Age (≥ 65)

1.310

0.587–2.919

F

Sex (male)

0.542

0.256–1.148

F

Location (right)

1.405

0.639–3.091

F

Depth of invasion

N.C

N.C

C

Venous invasion

N.C

N.C

C

Nodal metastasis (positive)

6.131

2.715–13.842

F

pTNM Stage

N.C

N.C

C

Postoperative chemtherapy (done)

18.117

7.043–46.604

F

Postoperative irradiation (done)

N.C

N.C

F

PDA (n = 98)

Age (≥ 65)

0.846

0.357–2.005

F

Sex (male)

0.658

0.284–1.524

F

Location (right)

1.179

0.503–2.761

F

Depth of invasion

N.C

N.C

C

Venous invasion

N.C

N.C

C

Nodal metastasis (positive)

2.991

1.084–8.252

F

pTNM Stage

N.C

N.C

C

Postoperative chemtherapy (done)

3.800

1.549–9.322

F

Postoperative irradiation (done)

N.C

N.C

F

MUA (n = 64)

Age (≥ 65)

0.882

0.257–3.029

F

Sex (male)

1.063

0.312–3.614

F

Location (right)

1.841

0.568–5.970

F

Depth of invasion

N.C

N.C

C

Venous invasion

N.C

N.C

C

Nodal metastasis (positive)

2.824

0.860–9.269

F

pTNM Stage

N.C

N.C

C

Postoperative chemtherapy (done)

8.750

2.314–33.080

F

Postoperative irradiation (done)

6.923

0.581–82.548

F

SRCC (n = 9)

Age (≥ 65)

0.100

0.004–2.504

F

Sex (male)

0.250

0.013–4.729

F

Location (right)

2.000

0.112–35.807

F

Depth of invasion

N.C

N.C

C

Venous invasion

N.C

N.C

C

Nodal metastasis (positive)

N.C

N.C

F

pTNM Stage

N.C

N.C

C

Postoperative chemtherapy (done)

10.000

0.399–250.419

F

Postoperative irradiation (done)

N.C

N.C

F